During the forecast period, the platelet-rich plasma market is expected to grow at a CAGR of 12.4%.
Due to a scarcity of antiviral treatments and the fact that Platelet Rich Plasma Market is considered an emergency treatment approach, the present COVID-19 pandemic has helped to boost the market. Platelet-rich plasma can be utilised for pain management during COVID-19, which is one of its advantages. This approach, which has previously been used to prevent surgery, is also beneficial in giving short-term pain relief in patients who are awaiting surgical clearance but do not want to be put off any longer by the side effects of steroids.
The rising prevalence of sports injuries, the growing number of cosmetic and surgical treatments, and the growing use of platelet-rich plasma in various therapeutic sectors are all contributing to the market's rise.
Read More @ https://cmiinfopiece.blogspot.com/2022/01/the-global-platelet-rich-plasma-market.html
